deltatrials
Terminated PHASE3 INTERVENTIONAL NCT00182247

D-Dimer and IPG for Recurrent Thrombosis (DIRECT)

D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study

Sponsor: Hamilton Health Sciences Corporation

Conditions Deep Vein Thrombosis Pulmonary Embolism
Interventions venogram
Updated 5 times since 2017 Last updated: Sep 13, 2005 Started: Dec 31, 1998 Completion: Jan 31, 2001
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Hamilton Health Sciences Corporation

More terminations from Hamilton Health Sciences Corporation

Other Deep Vein Thrombosis trials with similar outcome

Browse all Deep Vein Thrombosis trials

This PHASE3 trial investigates Deep Vein Thrombosis and Pulmonary Embolism and is currently terminated or withdrawn. Hamilton Health Sciences Corporation leads this study, which shows 5 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jan 2017 — Jan 2021 [monthly]

    Terminated PHASE3

    First recorded

Dec 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hamilton Health Sciences Corporation
  • Heart and Stroke Foundation of Canada
Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations